Sezary_syndrome_in_a_patient_with_hairy_cell_leukemia_in_remission._A_65-year-old_man_was_evaluated_for_pancytopenia_in_March_1979,_and_found_to_have_hairy_cell_leukemia_(HCL)._Treatment_with_splenectomy_and_subsequently_interferon_produced_temporary_remissions._In_July_1985,_the_patient_began_intravenous_deoxycoformycin_(DCF)_therapy,_and_after_1_year_complete_peripheral_blood_and_bone_marrow_remission_was_achieved._Fourteen_months_after_cessation_of_therapy,_the_patient_developed_a_skin_rash_and_was_found_to_have_cutaneous_T-cell_lymphoma_and_Sezary_syndrome._Morphologic_study_of_the_hairy_cells_(HC)_in_the_peripheral_blood_at_presentation_and_the_Sezary_cells_was_distinct_by_light_and_electron_microscopic_study._Immunophenotyping_of_peripheral_blood_mononuclear_cells_showed_clearly_that_the_HC_were_of_B-cell_origin_(CD20+,_sIg+),_whereas_the_lymphoid_population_at_second_presentation_was_T-cell_(CD3+,_CD4+,_HLA-DR-)._Clonal_rearrangement_of_T-cell_antigen_receptor_beta-chain_gene_was_detected_by_Southern_analysis_of_the_Sezary_cell_population,_whereas_immunoglobulin_heavy_and_light_chain_genes_remained_in_germ_line_configuration._This_is_the_first_case_of_Sezary_syndrome_developing_in_a_patient_previously_treated_for_HCL_where_studies_have_confirmed_distinct_B-cell_and_T-cell_origin_of_the_two_neoplasms._The_authors_suggest_that_treatment_and_disease-related_immunosuppression_are_possible_etiologic_factors_in_the_development_of_this_second_lymphoid_neoplasm.